JP2014533241A5 - - Google Patents

Download PDF

Info

Publication number
JP2014533241A5
JP2014533241A5 JP2014539111A JP2014539111A JP2014533241A5 JP 2014533241 A5 JP2014533241 A5 JP 2014533241A5 JP 2014539111 A JP2014539111 A JP 2014539111A JP 2014539111 A JP2014539111 A JP 2014539111A JP 2014533241 A5 JP2014533241 A5 JP 2014533241A5
Authority
JP
Japan
Prior art keywords
patent document
application publication
patent application
insulin
prior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014539111A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014533241A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/062423 external-priority patent/WO2013063572A1/en
Publication of JP2014533241A publication Critical patent/JP2014533241A/ja
Publication of JP2014533241A5 publication Critical patent/JP2014533241A5/ja
Pending legal-status Critical Current

Links

JP2014539111A 2011-10-27 2012-10-29 超濃縮速効型インスリン類似体製剤 Pending JP2014533241A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161552246P 2011-10-27 2011-10-27
US61/552,246 2011-10-27
PCT/US2012/062423 WO2013063572A1 (en) 2011-10-27 2012-10-29 Ultra-concentrated rapid-acting insulin analogue formulations

Publications (2)

Publication Number Publication Date
JP2014533241A JP2014533241A (ja) 2014-12-11
JP2014533241A5 true JP2014533241A5 (enExample) 2015-12-17

Family

ID=48168643

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014539111A Pending JP2014533241A (ja) 2011-10-27 2012-10-29 超濃縮速効型インスリン類似体製剤

Country Status (10)

Country Link
US (1) US9908925B2 (enExample)
EP (1) EP2771026A4 (enExample)
JP (1) JP2014533241A (enExample)
KR (1) KR20150021011A (enExample)
CN (1) CN104010652A (enExample)
AU (1) AU2012328407A1 (enExample)
BR (1) BR112014010139A2 (enExample)
IN (1) IN2014CN03888A (enExample)
SG (1) SG11201401835VA (enExample)
WO (1) WO2013063572A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015005662A (es) * 2012-11-05 2015-08-20 Univ Case Western Reserve Analogos de insulina de una sola cadena de larga accion.
CA2936563A1 (en) 2014-01-13 2015-07-16 Thermalin Diabetes, Llc Rapid action insulin formulations and pharmaceutical delivery systems
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
JP2017537065A (ja) * 2014-10-20 2017-12-14 ケース ウェスタン リザーブ ユニバーシティCase Western Reserve University 生物学的作用強度の高いハロゲン化インスリン類似体
AU2015349890B2 (en) * 2014-11-21 2018-08-30 Merck Sharp & Dohme Llc Insulin receptor partial agonists
WO2016105545A2 (en) * 2014-12-24 2016-06-30 Case Western Reserve University Insulin analogues with enhanced stabilized and reduced mitogenicity
BR112018002416A2 (pt) 2015-08-25 2018-09-18 Novo Nordisk As derivados de insulina e seus usos médicos
EP3341401A1 (en) 2015-08-25 2018-07-04 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
CN108368163A (zh) 2015-08-25 2018-08-03 诺和诺德股份有限公司 新型胰岛素衍生物及其医学用途
WO2017070617A1 (en) * 2015-10-21 2017-04-27 Case Western Reserve University Diol-modified insulin analogues containing a glucose-regulated conformational switch
HK1255634A1 (zh) 2015-12-23 2019-08-23 Case Western Reserve University 超稳胰岛素类似物在聚合物熔体中的包囊
TW202039437A (zh) * 2018-12-11 2020-11-01 法商賽諾菲公司 肽黏合劑
MA58093B1 (fr) 2019-12-11 2024-09-30 Novo Nordisk A/S Nouveaux analogues d'insuline et leurs utilisations
WO2024194897A1 (en) * 2023-03-22 2024-09-26 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) A glycation resistant insulin polypeptide and a method of preparing the same thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
WO1990001038A1 (en) 1988-07-20 1990-02-08 Nordisk Gentofte A/S Human insulin analogs and preparations containing them
US5474978A (en) 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US20030104981A1 (en) * 1995-11-03 2003-06-05 Jelena Mandic Human insulin analogues
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
EP1453860A2 (en) 2001-12-02 2004-09-08 Novo Nordisk A/S Novel glucose-dependant insulins
US7317000B2 (en) * 2001-12-02 2008-01-08 Novo Nordisk A/S Glucose-dependent insulins
CA2522818A1 (en) * 2003-03-11 2004-09-23 Soren Ostergaard Pharmaceutical preparations comprising acid-stabilised insulin
SE0401942D0 (sv) * 2004-07-28 2004-07-28 Lipopeptide Ab New antimicrobial peptide complexes
JP2008510692A (ja) * 2004-08-20 2008-04-10 ノボ ノルディスク アクティーゼルスカブ 薬学的に活性なインスリン受容体調節分子
EP2074140B8 (en) * 2006-10-04 2015-10-28 Case Western Reserve University Fibrillation-resistant insulin and insulin analogues
CA2703830A1 (en) 2007-11-20 2009-05-28 Ambrx, Inc. Modified insulin polypeptides and their uses
EP2318432B1 (en) * 2008-07-31 2015-09-02 Case Western Reserve University Halogen-stabilized insulin
KR20120129875A (ko) 2008-07-31 2012-11-28 케이스 웨스턴 리저브 유니버시티 염소화 아미노산을 갖는 인슐린 유사체
JP5789515B2 (ja) 2008-12-19 2015-10-07 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation インスリン類似体

Similar Documents

Publication Publication Date Title
JP2014519662A5 (enExample)
JP2014513484A5 (enExample)
JP2013517798A5 (enExample)
JP2014521827A5 (enExample)
JP2021524958A5 (enExample)
JP2010501534A5 (enExample)
CY1118442T1 (el) Μεθοδοι αγωγης δια της χρησεως εκλεκτικων αναστολεων bcl-2
JP2014520155A5 (enExample)
JP2015522045A5 (enExample)
JP2014221779A5 (enExample)
JP2014513036A5 (enExample)
JP2016506366A5 (enExample)
JP2015081257A5 (enExample)
JP2014509874A5 (enExample)
JP2013214010A5 (enExample)
JP2013524245A5 (enExample)
JP2013532130A5 (enExample)
JP2015510508A5 (enExample)
JP2017511377A5 (enExample)
JP2016506003A5 (enExample)
JP2012094862A5 (enExample)
BR112015007879A2 (pt) inibidores do vírus da hepatite c
JP2014508098A5 (enExample)
JP2016527801A5 (enExample)
JP2017528116A5 (enExample)